Thursday, October 14, 2021 11:15:55 AM
True!! This piggy never holds its gains, but I’m still in it for a 2022/23 payoff
Recent TARA News
- Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA • GlobeNewswire Inc. • 05/20/2026 12:00:00 PM
- Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC • GlobeNewswire Inc. • 05/15/2026 11:00:00 AM
- Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 05/13/2026 12:00:00 PM
- Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting • GlobeNewswire Inc. • 04/27/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:00:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 12:11:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 12:06:44 PM
- Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 03/10/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2026 10:51:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2026 10:50:16 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 03/06/2026 09:15:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 01:37:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 01:35:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 12:58:41 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 12:57:08 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/25/2026 02:13:47 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/25/2026 02:11:32 AM
- Protara reports encouraging Phase 2 results for TARA-002 in bladder cancer study • IH Market News • 02/24/2026 03:23:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 01:52:59 PM
- TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer • GlobeNewswire Inc. • 02/23/2026 10:05:00 PM
- Protara Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/19/2026 01:00:00 PM
- Form 424B7 - Prospectus [Rule 424(b)(7)] • Edgar (US Regulatory) • 02/02/2026 09:30:21 PM
- Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2026 09:05:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 09:10:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 09:10:13 PM
